A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
Condition(s):Kidney FailureLast Updated:February 24, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Kidney FailureLast Updated:February 24, 2020Completed
Condition(s):Pancreatic Cancer; Venous ThromboembolismLast Updated:December 12, 2016Completed
Condition(s):Venous ThromboembolismLast Updated:June 16, 2014Completed
Condition(s):Venous ThromboembolismLast Updated:January 8, 2019Completed
Condition(s):Venous Thromboembolism; Pulmonary EmbolismLast Updated:November 24, 2015Terminated
Condition(s):Liver Cirrhosis; Portal HypertensionLast Updated:January 8, 2019Unknown status
Condition(s):Covid19; ThrombosisLast Updated:September 15, 2022Completed
Condition(s):Pregnancy; Thrombophilia; Pregnancy ComplicationsLast Updated:May 19, 2014Completed
Condition(s):InfertilityLast Updated:April 19, 2017Unknown status
Condition(s):Covid19; ThromboembolismLast Updated:May 31, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.